Sequential Combination of Inotuzumab Ozogamicin (InO) with Low-Intensity Chemotherapy (mini-hyper-CVD) with or without Blinatumomab (Blina) As Salvage Therapy for Patients (Pts) with Acute Lymphoblastic Leukemia (ALL) in First Relapse
Year: 2020
Type: article
Study design: Clinical Trial
Source: Blood
Authors: Hind Rafei, Hagop M. Kantarjian, Koji Sasaki, Nicholas J. Short, Farhad Ravandi, Xuelin Huang, Joseph D. Khoury, Sa A Wang, Jeffrey L. Jorgensen, Issa F. Khouri, Partow Kebriaei, Nitin Jain, Bouthaina S. Dabaja, Yesid Alvarado, Tapan M. Kadia, Shilpa Paul, Serena Chew, Guillermo Garcia-Manero, Jan A. Burger, Courtney D. DiNardo, Naval Daver, Guillermo Montalban-Bravo, Musa Yilmaz, Maro Ohanian, Maria Khouri, Philip A. Thompson, Jovitta Jacob, Meagan Rostykus, Rebecca Garris, Marina Konopleva, Susan M. O'Brien, Elias Jabbour
Language: English
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3094669168